Centers for Disease Control and Prevention Centers for Disease Control and Prevention CDC Home Search CDC CDC Health Topics A-Z site search
National Office of Public Health Genomics
Centers for Disease Control and Prevention
Office of Genomics and Disease Prevention
Site Search
 

HuGENet Review
HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review

J.S. Dorman and C.H. Bunker on behalf of the students enrolled in Epidemiology 2600, “Introduction to Molecular Epidemiology”, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh.
back to review

 REFERENCES
  1. Germain RN. Antigen processing and presentation. In: Paul WE, ed. Fundamental Immunology, 3rd Edition. New York: Raven Press, 1993:pp.629-676.
  2. Janeway CA, Travers P, Hunt S, Walport M, Eds. Antigen recognition by T-lymphocytes. In Immunobiology: The Immune System in Health and Disease, Third Edition.New York, NY: Garland Publishing, 1997: 4:pp. 1-4:49.
  3. Kwok WW, Nepom GT. Genetic influences: Major histocompatability complex. In: The Autoimmune Diseases., 3rd edition.New York: Academic Press, 1998:75-83.
  4. Towsdale J, Campbell RD.The 12th international MHC map. In: Charron D. ed. Genetic diversity of HLA: functional and medical implications.Paris: EDK, 1997:pp. 499-504
  5. Khalil I, Deschamps I, Lepage V, et al. Dose effect of cis- and trans- encoded HLA DQαβ heterodimers in IDDM subjects. Diabetes 1992;41: 378-384.
  6. Dorman JS, McCarthy B, McCanlies E, and the WHO DiaMondMolecular Epiemiology Sub-Project Group. Molecular type 1 diabetes epidemiology: International studies. Diabetes Res Clin Pract 1996;34(Suppl):S107-116.
  7. WHO DiaMond Project Group.WHO Multinational project for Childhood diabetes.Diabetes Care 1990;13: 1062-68.
  8. Caillat-Zucman S, Djilali-Saiah I, Timsit J, et al. Insulin dependent diabetes mellitus (IDDM): 12th International Histocompatibility Workshop study.Charron D, ed. Genetic diversity of HLA: functional and medical implications. Paris: EDK, 1997:389-398.
  9. Abdulkadir J, Worku Y, Giphart MJ, et al. Susceptibility alleles at HLA-DRB1, -DQA1, and -DQB1 Loci in Ethiopian Childhood Insulin-Dependent Diabetes Mellitus. Human Immunology 1994; 41:171-172.
  10. Garcia-Pacheco JM, Herbut B, Cutbush S, et al. Distribution of HLA-DQA1, -DQB1 and DRB1 alleles in black IDDM patients and controls from Zimbabwe. Tissue Antigens 1992;40:145-149.
  11. Magzoub MMA, Stephens HAF, Gale EAM, et al. Identification of genetic susceptibility loci for insulin-dependent diabetes in Sudan.Scand. J. Immunol. 1992;36, Suppl. 11:187-191.
  12. Abdulkadir J, Worku Y, Giphart MJ, et al. Susceptibility alleles at HLA-DRB1, -DQA1, and -DQB1 loci in Ethiopian childhood insulin-dependent diabetes mellitus. Human Immunology 1994;41:171-172.
  13. Chauffert M, Cisse A, Chevenne D, et al. HLA-DQB1 typing and non-Aspalleles in the Aborigine population of Senegal. Diabetes Care 1995;18 No. 5:677-680.
  14. Huang HS, Peng JT, She, JY, et al. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as theirlinkage disequilibria in a Chinese population. Human Immunology 1995; 44: 210-219.
  15. Chuang LM, Jou TS, Hu CY, et al. HLA-DQB1 condon 57 and IDDM in Chinese living in Taiwan. Diabetes Care 1994: 17:863-868.
  16. Gorodezky C, Olivares A, Debazo H, et al. Los mechanismos moleculares de susceptibilidad y de proteccion dependientes del MHC en la diabetes tipo 1 en mexicanos. Gac Med Mex 1995; 131: 396-403.
  17. Cruickshanks KJ, Jobim LF, Lawler-Heavner J, et al. Ethnic differences in Human Leukocyte Antigen markers of susceptibility to IDDM. Diabetes Care 1994; 17 No. 2:132-137.
  18. Erlich HA, Zeidler A, Chang J, et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nature Genetics 1993;3:358-363.
  19. Gutierrez-Lopez MD, Bertera S, Chantres MT, et al. Susceptibility to type 1 (insulin-dependent) diabetes mellitus in Spanish patients correlates quantitatively with expression of HLA-DQα Arg-52 and HLA-DQβ non-Asp-57 alleles. Diabetologia 1992;35:583-588
  20. Rønningen KS, Spurkland A, Fait B, et al. HLA class II association in insulin-dependent diabetes mellitus among Blacks, Caucasians and Japanese. In: HLA 1991; 1:713-721.
  21. Todd JA, Mijovic C, Fletcher J, et al. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 1989;338:587-9.
  22. Todd JA, Bell JI, McDevitt HO. HLA-DQ β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987;329:599-604.
  23. Yamagata K, Hanafusa T, Nakojima H, et al. HLA-DQA1*1 contributes to resistance and A1*3 confers susceptibility to type 1 (insulin-dependent) diabetes in Japanese subjects. Diabetologia 1991; 34: 133-6.
  24. Trucco M. To be or not to be ASP57: That is the question. Diabetes Care 1992; 15: 705-715.
  25. Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993;36:371-377.
  26. She JY. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunology Today 1996;17:323-9.
  27. LaPorte RE, Matsushima M, Chang YF.Prevalence and incidence of insulin-dependent diabetes. In: National Diabetes Data Group(ed).Diabetes in America, NIH, 1995;pp.37-46
  28. Karvonen M, Pitkniemi M, Pitkniemi J, et al. Sex difference in the incidence of insulin-dependent diabetes mellitus: An analysis of the recent epidemiological data. Diabetes Metab Rev 1997;13:275-91.
  29. Levy-Marchal C, Patterson E, Green A, et al. Variation by age group and seasonality at diagnosis of childhood type 1 diabetes in Europe. Diabetologia 1995;38: 823-30.
  30. Diabetes Epidemiology Research International Group (DERI). Secular trends in incidence of childhood type 1 diabetes in 10 countries. Diabetes 1990;39:858-64.
  31. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J.Worldwide increase in incidence of Type 1 diabetes - the analysis of the data on published incidence trends. Diabetologia 1999; 42:1395-1403.
  32. Matsuura N, Fukuda K, Okuno A, et al. Descriptive epidemiology of type 1 diabetes in Hokkaido, Japan: The Childhood type 1 diabetes Hokkaido Registry. Diabetes Care1998;21:1632-6.
  33. Tajima N, Laporte RE, on behalf of WHODIAMOND project group.Incidence of IDDM outside Europe.Pediatric and Adolescent Endocrinology 1992; 21:31-41.
  34. Tull ES, Roseman JM, Christian CLE.Epidemiology of Childhood IDDM in U.S. Virgin Islands from 1979 to 1988. Evidence of an Epidemic in Early 1980's and Variation by Degree of Racial Admixture. Diabetes Care 1991;14: 558-564.
  35. Karvonen M, Tuomilehto J, Libman I, LaPorte R. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993;36:883-92.
  36. Yang, Z. et al. Childhood diabetes in China. Diabetes Care 1998;21: 525-9.
  37. Karvonen M, Rusanen J, Sundberg M, et al. Regional differences in the incidence of insulin-dependent diabetes mellitus among children in Finland from 1987-1991. Annals of Med 1997; 29: 297-304.
  38. Foulis AK. The pathology of the endocrine pancreas in type I (insulin dependent) diabetes mellitus. APMIS 1996;104: 161-167.
  39. von Herrath MG, Holz A, Homann D, et al. Role of viruses in type I diabetes. Seminars in Immunology: Diabetes and Viruses 1998;10: 87-100.
  40. Graves M, Norris JM, Pallansch MA, et al. The role of enteroviral infections in the development of IDDM. Limitations of current approaches. Diabetes 1997; 46:161-168.
  41. Andrcoletti L, Hober D, Hober-Vandenberghc C, et al. Coxsackie B virus infection and beta cell autoantibodies in newly diagnosed IDDM adult patients. Clin Diagn Virol 1998; 9:125-33.
  42. Clements GB, Galbraith DN, Taylor KW.Coxsackie B virus infection and onset of childhood diabetes. The Lancet 1995;346:221-223.
  43. Hou J, Sid C, Franchi D, et al. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients. Diabetes 1994; 43:1260-1266.
  44. Vreugdenhil GR, Batstra MR, Aanstoot HJ, et al. Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65). J Med Virol 1999; 59:256-
  45. Lonnrot M, Knip M, Roivainen M, et al. Onset of type I diabetes mellitus in infancy after enterovirus infections. Diabetic Medicine 1998;15: 431-434.
  46. Hyoty H, Hiltunen M., Reuranen A, et al. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children with a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Diabetologia 1993;36:1303-1308.
  47. Hyoty H, Hiltunen M, Knip M, et al. A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44:652-7.  
  48. Dahlquist GG, Ivarsson S, Lindberg B, et al. Maternal eneroviral infection during pregnancy. Diabetes 1995; 44:408-13.
  49. McIntosh EDG, Menser M. A fifty-year follow-up of congenital rebella. Lancet 1992; 340:414-415.
  50. ScottFW. Cow milk and insulin-dependent diabetes mellitus: is there a relationship? Am J Clin Nutr 1990;51:589-91.
  51. Norris JM, Scott FW. A Meta-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role? Epidemiology 1996;7:87-92.
  52. Kolb H, Pozzilli P. Cow's milk and type 1 diabetes: the gut immune system deserves attention. Immunology Today 1999;20:108-110.
  53. Karjalainen J, Martin JM, Knip M, et al.A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. NEJM 1992; 327: 302-307.
  54. Atkinson MA., et al. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 1993;329: 1853-58.
  55. Ellis TM, Ottendorfer E, Jodoin E. et al. Cellular immune responses to ß casein: elevated in but not specific for individuals with type 1 diabetes mellitus. Diabetologia 1998; 41:731-735.
  56. Norris JM, Beaty B, Eisenbarth GS, et al. Lack of association betweeninfant diet and prediabetic autoimmunity in high genetic risk children. The Diabetes Autoimmunity Study in the Young (DAISY). Diabetes 1995; 44 (Suppl 1):6A.
  57. Dorman JS. Molecular epidemiology of insulin-dependent diabetes mellitus. Epidemiologic Reviews 1997; 19:91-98.
  58. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position57 of the HLA-DQ ß chain protects against type I diabetes: A family study. Proc. Nat. Acad. Sci. USA 1988;85:8111-8115
  59. Nepom GT, Kwok WW. Molecular basis for HLA-DQ associations with IDDM. Diabetes1998;47:1177-1184.
  60. Dorman JS, LaPorte RE, Stone RA, et al. Worldwide differences in the Incidence of type 1 diabetes are associated with amino acid variation at point 57 of the HLA-DQB chain. PVAS1990; 87:7370-7374.
  61. Sanjeevi CB, Hook P, Landin-Olsson M, et. al. DR4 subtypes and their molecular properties in a population-based study of Swedish childhood diabetes. Tissue Antigens 1996; 47:275-283
  62. Yasunaga S, Kimera A, Hamaguchi K, et al. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (type 1 diabetes). Tissue Antigens 1996; 47: 37-48.
  63. Undlien DE, Friede T, Rammensee H, et al. HLA-encoded genetic predisposition in type 1 diabetes: DR4 subtypes may be associated with different degrees of protection. Diabetes1997; 46:143-9.
  64. Nejentsev S, Reijonen, H, Adojaan B, et al. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 1997; 46:1888-1892.
  65. Reijonen H, Nejentsev S, Tuokko J, et al. HLA-DR4 subtype and -B alleles in DQB1*0302-positive haplotypes associated with IDDM. European Journal of Immunogenetics 1997; 24:357-363.
  66. Djoulah S, Busson M, Sasazuki T, et al. A new predictive model for insulin-dependent diabetes mellitus susceptibility based combinations of molecular HLA-DRB1 and HLA-DQB1 pockets. Tissue Antigens 1999;54:341-348
  67. Bennett ST, Wilson AJ, Esposito L, et al. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nature Genetics 1997;17:350-352.
  68. Pugliese A, Zeller M, Fernandez A Jr., et al. The insulin gene is transcribed in human thymus and transcription levels correlated with allelic variation at the INS VNTR-type 1 diabetes2 susceptibility locus for type 1 diabetes. Nature Genetics. 1997;15: 293-297.
  69. Undlien DE, Hamaguchi K, Kimura A, et al. Type 1 diabetes susceptibility associated with polymorphism in the insulin gene region: a study of blacks, Caucasians, and orientals. Diabetologia1994;37:745-749.
  70. Kawaguchi Y, Ikegami H, Shen GO, et al. Insulin gene region contributes to genetic susceptibility to, but may not to low incidence of, insulin-dependent diabetes mellitus in Japanese. Biochemical and Biophysical Research Communications 1997; 233:283-287.
  71. Van der Auwera B, Schuit F, Lyaruu I, et al. The Belgian Diabetes Registry. Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisted: the importance of diabetes registries in disclosing interactions between HLA-DQ and insulin gene-linked risk. Journal of Clinical Endocrinology and Metabolism 1995; 80: 2567-2573.
  72. MetcalfKA, Hitman GA, Fennessy MJ, et al. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. Diabetologia 1995;38: 1223-1229
  73. She JX, Bui MM, Tian XH et al. Additive susceptibility to insulin-dependent diabetes conferred by HLA-DQB1 and insulin genes. Autoimmunity 1994;18: 195-203.
  74. Bain SC, Prins JB, Hearne CM, et al. Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nature Genetics 1992; 2:212-215
  75. Julier C, et al. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 1991; 354:155-59
  76. Kostraba, JN. et al. Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of type 1 diabetes. Diabetes 1993;42(2):288-95.
  77. Perez-Bravo F, Carrasco E, Gutierrez-Lopez MD, et all. Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children. J Mol Med 1996; 74:105-109.
  78. Saukkonen,T, et al. Significance of cow's milk protein antibodies as risk factor for childhood type 1 diabetes: interactions with dietary cow's milk intake and HLA-DQB1 genotype. Diabetologia 1998; 41:72-78.
  79. Mytilineos J, Scherer S, Opelz G. Comparison of RFLP-DR beta and serologic HLA-DR typing in 1500 individuals. Transplantation 1990; 5:870-873.
  80. Otten HG, Tilanus MGJ, Barnstijn M, et al. Serology versus PCR-SSP in typing for HLA-DR and HLA-DQ: a practical evaluation. Tissue Antigens 1995; 45:36-40.
  81. Ng J, Hurley CK, Baxter-Lowe LA, et al. Large-scale oligonucleotide typing for HLA-DRB1/3/4 and HLA-DQB1 is highly accurate, specific, and reliable. Tissue Antigens 1993; 42: 473-479.
  82. Olerup O, Zetterquist H.HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serologic DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39: 225-235.
  83. Akerblom HK, Savilahti E, Savkkonen TT, et al. The case for elimination of cow's milk in earlyinfancy in the prevention of type 1 diabetes:The Finnish experience. Diab.Metab Rev. 1993;9:269-278.
  84. Verge CF, Gianani R, Kawasaki E, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45:926-933.
  85. Bingley PJ, Christie, MR, Bonifacio E, et al. Combined analysis of autoantibodies improvesprediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43:1304-1310.
  86. Dittler J, Seidel D, Schenker M, et al. GADIA2-combi determination as first-line screening for improved prediction of type I diabetes in relatives. Diabetes 1998; 47:592-597.
  87. Pastore MR, Bazzigaluppi E, Bonfanti R, et al. Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives. Diabetes Care 1998: 21: 1445-1450.
  88. DPT-1 Study Group. The Diabetes Prevention Trial - type 1 diabetes (DPT-1):implementation of screening and staging of relatives. Transplantation Proceed. 1995; 27:3377.
  89. Ilonen J, Reijonen H, Herva E. et al. Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. Diabetes Care 1996;19:795-800.
  90. Ilonen J, Simell O, Knip M, et al. Screening for genetic IDDM risk and prevention trials in infancy. Diab Metab. Rev. 1998; 14:188.
  91. Rewers M, Bugawan TL, Norris JM, et al. Newborn screening for HLA markers associated with type 1 diabetes: Diabetes autoimmunity study in the young (DAISY). Diabetologia 1996; 39: 807-812
Page last reviewed: January 1, 2000 (archived document)
Page last updated: November 2, 2007
Content Source: National Office of Public Health Genomics